renal autologous cell therapy
Cell therapyexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Aug 13, 2019 (NCT04115345)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05694169 | Phase 1 | Jul 11, 2023 | Prokidney |
| NCT05286853 | Phase 3 | Jan 31, 2023 | IQVIA, Prokidney |
| NCT05099770 | Phase 3 | Nov 30, 2021 | IQVIA, PPD, Prokidney |
| NCT05018416 | Phase 2 | Jul 27, 2021 | Prokidney |
| NCT04115345 | Phase 1 | Aug 13, 2019 | CTI Clinical Trial and Consulting Services, inRegen |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Prokidney | For profit | 4 | 4 | 3 | 2021 |
| IQVIA | For profit | 2 | 0 | 1 | 2021 |
| CTI Clinical Trial and Consulting Services | For profit | 1 | 0 | 1 | 2019 |
| inRegen | For profit | 1 | 1 | 1 | 2019 |
| PPD | For profit | 1 | 0 | 1 | 2021 |
5 organizations
Page 1 / 1